Download or read book Direct to Consumer DTC Advertising of Prescription Medications on the World Wide Web Assessing the Communication of Risks and Benefits written by and published by . This book was released on 2001 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Recently, pharmaceutical manufacturers have begun using direct-to-consumer (DTC) advertisements to convey prescription medication information directly to consumers. The current research explores several factors that may influence the communication of risk and benefit information in DTC advertisements on the World Wide Web (WWW). Specifically, this study focused on the effects of integrating and separating risk and benefit information at different levels of a DTC prescription medication advertisement web site hierarchy. The study also examined how risk/benefit information placement was affected by a user's information processing objective (IPO) or task type. IPO was manipulated by requiring participants to either perform a general browsing task or a search and find task. To extend the generalizability of the results, two prescription medication DTC advertisement web sites were used in the study. Risk and benefit recall, recognition, time-on-task, amount of information found, web site click rates, and risk-noticability ratings were measured to compare the effects of integrating and separating the risk and benefit information on the same web page and on different web pages at different levels of a DTC medication advertisement web site, task type, and drug. Results from the current study indicated that risk and benefit information was found faster, with less clicks, and remembered more often when it is placed higher in the web site hierarchy, and presented in separate sections. The pattern of results for the two tasks used in the current study was similar and no significant differences were found between the two drugs. Participant ratings indicated a strong preference for risk information placed separate from other information on the home page. Finally, participants who were more experienced with surfing the web and online shopping tended to have better performance scores. The results suggest that the current U.S. Federal regulations regarding DTC prescription medicatio.
Download or read book Direct to consumer DTC Advertising of Prescription Medications on the World Wide Web written by William John Vigilante (Jr.) and published by . This book was released on 2001 with total page 341 pages. Available in PDF, EPUB and Kindle. Book excerpt: Keywords: direct-to-consumer, prescription medications, drugs, web site, usability, warnings, safety.
Download or read book Developing Trust in Direct to consumer Prescription Drug Advertising written by Jennifer Gerard Ball and published by . This book was released on 2011 with total page 436 pages. Available in PDF, EPUB and Kindle. Book excerpt: Trust in direct-to-consumer (DTC) pharmaceutical advertising is declining among consumers. Survey findings suggest providing more information about side effects and benefits to address this issue. Some scholars also criticize the ads for their emotional content despite the key role emotion can play in health-related decision making and trust. Therefore, an experimental study was conducted to assess the relative effectiveness of functional and emotional benefit communication as well the preferred balance of side effects and benefits information provided in DTC pharmaceutical ads in terms of perceived credibility/trust and persuasive outcomes. Results suggest a message including a combination of functional and emotional benefits is considered more credible and informative than an ad describing only emotional benefits. In addition, a high amount of side effect information produces lower brand attitudes and greater perceptions of manipulative intent compared to a low amount of side effect information. Implications for pharmaceutical advertising practitioners and researchers are discussed.
Download or read book Prescription Drugs written by United States. General Accounting Office and published by . This book was released on 1991 with total page 24 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Prescription Drugs written by United States. General Accounting Office and published by . This book was released on 1991 with total page 40 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Direct to consumer Advertising of Prescription Drugs written by United States. Congress. Senate. Special Committee on Aging and published by . This book was released on 2003 with total page 152 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book the impact of direct to consumer drug advertising on seniors health and health care costs written by and published by DIANE Publishing. This book was released on with total page 128 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book The Impact of Direct to consumer Drug Advertising on Seniors Health and Health Care Costs written by United States. Congress. Senate. Special Committee on Aging and published by . This book was released on 2006 with total page 130 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Prescription Drug Advertising to Consumers written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations and published by . This book was released on 1984 with total page 276 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Prescription Drugs Trends in FDA s Oversight of Direct to Consumer Advertising written by Marcia Crosse and published by DIANE Publishing. This book was released on 2008-10 with total page 19 pages. Available in PDF, EPUB and Kindle. Book excerpt: The FDA is responsible for overseeing direct-to-consumer (DTC) advertising (ad) of prescription drugs, which includes TV, magazines, and the Internet. If FDA identifies a violation of laws or reg¿s. in a DTC ad material, the agency may issue a regulatory letter (RL) asking the drug co. to take specific actions. In 2002, there were delays in FDA¿s issuance of these RL. This testimony discusses trends in FDA¿s oversight of DTC ad and the actions FDA has taken when it identifies violations. This statement discusses the: (1) DTC ad materials FDA reviews; (2) FDA¿s process for issuing RL citing DTC ad materials and the number of RL issued; and (3) the effectiveness of FDA¿s RL at limiting the dissemination of false or misleading DTC ad. Charts and tables.
Download or read book Highlighting Validity and Placement of Risk Information in Drug Manufacturers Direct to consumer Web Pages written by and published by . This book was released on 2004 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Since the mid-1980s, direct-to-consumer (DTC) advertising has changed the way a pharmaceutical company markets prescription medications. DTC advertising has steadily become an integral way of communicating information about prescription drugs to end users and research has shown that the helpInternet is growing as a potential source of drug information. The current study examined the effects of colored highlighting validity (Valid, Invalid and No highlighting) and placement (Top, Middle and Bottom) of target risk keywords in web pages using two kinds of visual search tasks. The two tasks were the same except that in one a target was always present and in the other the target was either present or absent. For both tasks dependent variables were response time and accuracy. The results indicate that valid highlighting significantly reduced response time and increased accuracy across both tasks. Invalid highlighting was not significantly different compared to no highlighting for both tasks in terms of response time or accuracy. Results for both tasks also showed that placement of target keywords on a web page had a significant effect. Top and middle placements significantly reduced response time and increased accuracy compared to placement at the bottom. Findings suggest that valid highlighting and placement above the fold (Top and Middle) of a web page could facilitate consumers locating risk information. In general highlighting has benefits when the sought information is validly highlighted but has no cost when non-target information is highlighted instead. The present findings confirm the results found in studies in other domains. Implications for potential application of highlighting and placement and for future research are discussed.
Download or read book Direct to consumer Advertising written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations and published by . This book was released on 2008 with total page 556 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Evaluating the Influence of Presentation Modality on the Communication of Pharmaceutical Risk Information in Direct to Consumer DTC Television Commercials written by and published by . This book was released on 2003 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Direct-to-consumer prescription drug advertising markets medications requiring a physician's script to the general public. Currently, the Food and Drug Administration mandates that direct-to-consumer prescription drug advertising include risk disclosures (i.e., side effects and contraindications) in auditory (voice) or both auditory and visual (text) parts of the commercials. Little research has examined the factors that affect the communication of risk disclosures. The present research was conducted to identify what factors influence recall and recognition of risk disclosures in direct-to-consumer prescription drug television commercials. Three issues were investigated. One was to determine if concurrently presented visual and auditory risk disclosures produced greater recall and recognition than either presented independently. A second issue is whether recall and recognition is better for visual risk disclosures compared to auditory or vise versa. A third issue is whether concurrently presented non-risk disclosures in a competing modality would negatively affect risk disclosure recall and recognition. The results showed several effects. The first was that risk disclosures presented either visually, auditorily, or combined increased the likelihood of recall and recognition compared to no presentation. Second, risk disclosures presented concurrently in visual and auditory modalities produced the highest recall and recognition. Third, the results indirectly support the idea that presentation of visual risk disclosures produces better recall and recognition compared to auditory risk disclosures. Finally, concurrent presentation of non-risk disclosures with risk disclosures produced lower recall and recognition compared to presenting only risk disclosures. Implications for the design of direct-to-consumer prescription drug television commercials as well as directions for future research are discussed.
Download or read book Selling Sickness written by Ray Moynihan and published by Greystone Books. This book was released on 2008-09-01 with total page 171 pages. Available in PDF, EPUB and Kindle. Book excerpt: In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. Selling Sickness reveals how expanding the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. This Canadian edition includes an introduction placing the issue in a Canadian context and describing why Canadians should be concerned about the problem.
Download or read book The Future of Drug Safety written by Institute of Medicine and published by National Academies Press. This book was released on 2007-02-27 with total page 346 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the wake of publicity and congressional attention to drug safety issues, the Food and Drug Administration (FDA) requested the Institute of Medicine assess the drug safety system. The committee reported that a lack of clear regulatory authority, chronic underfunding, organizational problems, and a scarcity of post-approval data about drugs' risks and benefits have hampered the FDA's ability to evaluate and address the safety of prescription drugs after they have reached the market. Noting that resources and therefore efforts to monitor medications' riskâ€"benefit profiles taper off after approval, The Future of Drug Safety offers a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.
Download or read book Marketing Or Medicine written by United States. Congress. Senate. Special Committee on Aging and published by . This book was released on 2009 with total page 104 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Handbook of Warnings written by Michael S. Wogalter and published by CRC Press. This book was released on 2006-01-20 with total page 872 pages. Available in PDF, EPUB and Kindle. Book excerpt: A technical discussion that includes theory, research, and application, this book describes warning design standards and guidelines; aspects of law relevant to warnings such as government regulations, case/trial litigation, and the role of expert testimony in these cases; and international, health/medical, and marketing issues. Broken into thirteen
